Follow-up of pregnant women exposed to chicken pox: an audit of relationship between level of antibody and development of chicken pox
- 1 April 2011
- journal article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 30 (10), 1193-1200
- https://doi.org/10.1007/s10096-011-1211-4
Abstract
The purpose of this study was to validate through natural exposure a cut-off level of varicella zoster IgG as protective against infection with varicella zoster virus (VZV). Laboratory testing to determine VZV immune status of pregnant women exposed to varicella is recommended. Quantitative assays are now available which are sensitive and specific. More than 200 consecutive requests for screening in pregnant patients with recent varicella contacts were followed-up by questionnaire. DiaSorin LIAISON and VZV time resolved fluorescence immuno assay (VZV TRFIA) were used to measure VZV antibody level. One hundred fifty out of 209 (72%) questionnaires were returned; 14 patients developed varicella, 129 did not and seven were not known. Patients who had been given VZIG and developed varicella on follow-up had a mean antibody level before VZIG of 28 mIU/ml and 62 mIU/ml, by LIAISON and TRFIA, respectively. The mean IgG level of those that did not develop varicella was 885 and 866 mIU/ml by LIAISON and TRFIA, respectively. Those with levels 100 mIU/ml (relative risk of 10.4 for LIAISON and 8.8 for TRFIA). On the basis of the relatively small numbers in this study, quantitative assays, using a 100mIU/ml cut-off, can differentiate between those who are susceptible and those who are protected against exposure, however follow-up studies should include sampling for VZV DNA and IgM.Keywords
This publication has 14 references indexed in Scilit:
- Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workersJournal of Virological Methods, 2011
- Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infectionJournal of Virological Methods, 2009
- Comparison of fifteen commercial assays for detecting Varicella Zoster virus IgG with reference to a time resolved fluorescence immunoassay (TRFIA) and the performance of two commercial assays for screening sera from immunocompromised individualsJournal of Virological Methods, 2009
- Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assayJournal of Clinical Virology, 2009
- Varicella and the pregnant woman: Prevention and managementAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2008
- Performance of a Time-Resolved Fluorescence Immunoassay for Measuring Varicella-Zoster Virus Immunoglobulin G Levels in Adults and Comparison with Commercial Enzyme Immunoassays and Merck Glycoprotein Enzyme ImmunoassayClinical and Vaccine Immunology, 2006
- Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 casesThe Lancet, 1994
- Epidemiology, outcome and control of varicella-zoster infectionReviews in Medical Microbiology, 1993
- Fetal varicella syndromeThe Journal of Pediatrics, 1987
- Serologic Response to Varicella-Zoster Membrane Antigens Measured by Indirect ImmunofluorescenceThe Journal of Infectious Diseases, 1974